P

Prestige Consumer Healthcare
D

PBH

84.780
USD
0.64
(0.76%)
Market Closed
Volume
4,411
EPS
4
Div Yield
-
P/E
21
Market Cap
4,188,594,390
OverviewSignalsIdeasNews
Related Instruments
    A
    ABC
    0
    (0%)
    0.000000 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    294.4 USD
    C
    CAH
    -2.540
    (-2.09%)
    118.790 USD
    CVS
    CVS
    -1.920
    (-3.48%)
    53.190 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    155.14 USD
    MCK
    MCK
    -3.56
    (-0.58%)
    606.42 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    99.16 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.63 USD
    R
    RAD
    -0.13430
    (-17.23%)
    0.64500 USD
    W
    WBA
    -0.34000
    (-3.86%)
    8.47500 USD
    More
News

Title: Prestige Consumer Healthcare

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.